ICT MEDICAL / MEDICAL & AESTHETIC TECHNOLOGIESFOR PROFESSIONAL PARTNERS
SI BELLE / INDIVIDUAL PRODUCT PROFILE

Si Belle PLLA+ 400

PLLA + HA composition profile

The supplied PLLA+ 400 box declares poly-L-lactic acid and purified hyaluronic acid, with a total labelled content of 400 mg per vial.

Original PLLA+ 400 packaging supplied by the client; not regenerated.
Original PLLA+ 400 packaging supplied by the client; not regenerated.
PRODUCT INFORMATION

Product identity.

The supplied PLLA+ 400 box declares poly-L-lactic acid and purified hyaluronic acid, with a total labelled content of 400 mg per vial.

400 mg × 1 vial — pack declaration

SOURCE · Original PLLA+ 400 box artwork; portfolio p.10
PRODUCT INFORMATION

What the source declares.

FieldSource-supported information
Poly-L-lactic acid340 mg — pack declaration
Purified hyaluronic acid60 mg — pack declaration
Total labelled content400 mg × 1 vial
Pack wordingFUNCTION: Facial Serum; For external use only; For professional use only
SOURCE · Original PLLA+ 400 box artwork; portfolio p.10
PRODUCT INFORMATION

Scope of the current product information.

Full formulation, intended use, storage, shelf life and market status should be checked against the current model-specific documents before supply. No treatment instructions or outcomes are inferred from the product name.

SOURCE · Original PLLA+ 400 box artwork; portfolio p.10
PROFESSIONAL RESOURCES

Request this product’s documents.

Source documentOriginal pack artwork and family portfolio reference
Request document ↗
Current IFU & specificationRequest the current model-specific instructions and technical data.
Request document ↗
Market-specific documentationRequest classification and supply-status documentation for your country.
Request document ↗
ICT MEDICAL / PROFESSIONAL ENQUIRIES

Discuss the product. Request the right documents.

Product information · Technical documentation · Partnership discussions

Speak with ICT Medical